LDOS — Leidos Holdings, Inc.

Leidos Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Revenue: $4.4 billion, up 4% year-on-year (3% organic growth).
• Adjusted EBITDA: $614 million, reflecting a margin of 14%, up 2% year-on-year.
• Non-GAAP Diluted EPS: Increased by 5% to $3.13, driven by higher adjusted EBITDA, lower share count, and a reduced tax rate.
• Cash Flow: Generated $301 million from operating activities and $270 million in free cash flow.
• Debt: Ended the quarter with $6.3 billion in debt and a gross leverage ratio of 2.6x.

2. Strategic Updates and Business Highlights:

• NorthStar 2030 Growth Strategy: Execution is underway, focusing on five growth pillars: Defense Tech, managed health, digital infrastructure and cyber, energy resilience, and mission software.
• Acquisitions: The Entrust acquisition is expected to be accretive to non-GAAP EPS and cash in 2026, with integration ahead of schedule.
• Defense Sector: Strong demand with over $9 billion in awards in the last 15 months. Key programs include the AGM-190A small cruise missile and the ALPS product under a $2.2 billion contract.
• Health Sector: Secured a $456 million Military OneSource award and initiated a pilot for an AI-driven medical record transfer tool.
• Joint Ventures: Announced a joint venture with Analogic to strengthen the Homeland Defense sector.

3. Forward Guidance and Outlook:

• Revenue Guidance: Raised by $500 million to a range of $18 billion to $18.4 billion for 2026.
• Adjusted EBITDA Margin: Maintained in the mid-13% range.
• Non-GAAP Diluted EPS Guidance: Increased by $0.05 to a range of $12.10 to $12.50.
• Operating Cash Flow Guidance: Increased by $50 million to approximately $1.8 billion.
• Q2 Expectations: Anticipated to be a low point for revenue growth and margins, with a recovery expected in the second half of the year.

4. Bad News, Challenges, or Points of Concern:

• Defense Profitability: Experienced a decline in margins (from 9.8% to 8.3%) due to delays in fixed-price development programs.
• Q2 Revenue Dip: Expected lower revenue and margins in Q2, attributed to program transitions and the absence of a one-time insurance reimbursement.
• Market Conditions: Procurement processes are still recovering from previous government shutdowns, which may impact near-term growth.

5. Notable Q&A Insights:

• Defense Sector Concerns: Profitability challenges linked to specific programs, but management remains optimistic about upcoming projects with superior economic profiles.
• CapEx Plans: Initial plans to triple CapEx may be adjusted based on actual needs; management emphasizes prudent capital allocation.
• Health Business Outlook: While facing a reset in revenue and margins, management remains bullish on long-term growth, especially through technology investments and new contracts.
• Maritime Demand: Increased interest in autonomous vessels from the Navy, with expectations for significant future contracts.
• Entrust Integration: Positive customer reception and rapid growth anticipated in the energy sector as a result of the acquisition.

Overall, Leidos reported a strong start to 2026, with solid financial performance and strategic initiatives aimed at long-term growth, despite facing some near-term challenges in revenue and profitability.